If Dominissini validates Zan as an FTO inhibitor; the market opportunity goes from 'niche aml chemotherapeutic' to 'every cancer subset where fto expression is high and every cancer treatment that upregulates fto expression (almost all of them)'.
Holders would be better off digesting the magnitude of this potential revelation rather than concerning themselves with overseas listing's.
- Forums
- ASX - By Stock
- Industry news
If Dominissini validates Zan as an FTO inhibitor; the market...
-
-
- There are more pages in this discussion • 1,425 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.81 |
Change
-0.030(1.63%) |
Mkt cap ! $307.6M |
Open | High | Low | Value | Volume |
$1.85 | $1.94 | $1.77 | $230.8K | 124.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15405 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.85 | 1750 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15405 | 1.785 |
1 | 200 | 1.780 |
2 | 1600 | 1.760 |
3 | 8043 | 1.750 |
1 | 2865 | 1.745 |
Price($) | Vol. | No. |
---|---|---|
1.850 | 1750 | 1 |
1.860 | 380 | 1 |
1.880 | 2351 | 1 |
1.895 | 7800 | 1 |
1.900 | 159 | 1 |
Last trade - 16.10pm 25/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, Managing Director and Executive Chairman
David Breeze
Managing Director and Executive Chairman
SPONSORED BY The Market Online